SCHEMBL21985787

SCHEMBL21985787

CC(CO)C(=O)N(c1cccnc1)C1C=CC(=O)C=C1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 2/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ CYP2B6 P20813 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ LMNA P02545 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ KCNA5 P22460 6/20 0.33
▸ TBXAS1 P24557 2/20 0.33
▸ PIK3CD O00329 1/20 0.33
▸ NOTUM Q6P988 1/20 0.33
▸ TRPV1 Q8NER1 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ GFER P55789 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ NPC1 O15118 1/20 0.32
▸ RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22662071 0.87 CYP3A4 (0.38) CYP3A4CYP2C9CYP2B6CYP2C19LMNA
SCHEMBL21988022 0.74 LMNA (0.35) CYP3A4CYP2C9CYP2B6CYP2C19LMNA
Hydrochloric Acid SCHEMBL20641545 0.73 LMNA (0.41) CYP3A4CYP2C9CYP2B6CYP2C19LMNA
SCHEMBL19963118 0.72 GAA (0.39) CYP3A4CYP2C9CYP2B6CYP2C19HTT
SCHEMBL20544294 0.71 CYP3A4 (0.34) CYP3A4CYP2C9CYP2B6CYP2C19LMNA
SCHEMBL19963087 0.70 CYP3A4 (0.40) CYP3A4CYP2C9CYP2B6CYP2C19LMNA
SCHEMBL29594970 0.70 CYP3A4 (0.40) CYP3A4CYP2C9CYP2B6CYP2C19LMNA
SCHEMBL5225657 0.63 NOTUM (0.48) CYP3A4CYP2C9CYP2B6CYP2C19LMNA
SCHEMBL8132461 0.62 HTT (0.43) CYP3A4CYP2C9CYP2B6CYP2C19LMNA
SCHEMBL8232133 0.62 CYP3A4 (0.46) CYP3A4CYP2C9CYP2B6CYP2C19LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10836734-B2 Spiroquinone derivative compound, production method thereof, and pharamaceutical composition for preventing or treating neurological disorders which contains same as active ingredient GACHON UNIVERSITY OF INDUSTRY—ACADEMIC COOPERATION FOUNDATION (KR) 2020-11-17 — — US disclosed
EP-3395804-B1 NOVEL SPIROQUINONE DERIVATIVE COMPOUND, PRODUCTION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NEUROLOGICAL DISORDERS WHICH CONTAINS SAME AS ACTIVE INGREDIENT UNIV GACHON IND ACAD COOP FOUND (KR) 2020-05-13 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10836734-B2 Spiroquinone derivative compound, production method thereof, and pharamaceutical composition for preventing or treating neurological disorders which contains same as active ingredient NQO1, SDHA, SDHB CYP3A4 701/4885CYP2C9 447/4885CYP2B6 483/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback